5AM Venture Management, LLC Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001799883

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2023 · 26 positions · Total reported value $347.54M · Top-10 concentration 74.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 43.8% · 0 new · 6 cut · 1 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -23.4% · vs SPY -25.5% · Prev Value $287.89M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -24.1% · vs SPY -26.3% · Latest Value $297.01M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2023 13F filing, 5AM Venture Management, LLC disclosed 26 equity positions with a combined reported value of $347.54M. The filing implies a focused portfolio: its ten largest positions account for 74.9% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2023 were ELVN ($70.50M), TRDA ($69.65M), IRON ($20.60M). By sector, the heaviest allocations are Health Care 87.3%, Other 12.7%.

Versus the prior quarter, 5AM Venture Management, LLC opened 0 new positions, trimmed 6 and fully exited 1, a turnover rate of 43.8% of positions.

The largest new positions opened in Q3 2023 were ELVN ($70.50M), TRDA ($69.65M), IRON ($20.60M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2023)

  • ELVN ENLIVEN THERAPEUTICS INC · $70.50M
  • TRDA ENTRADA THERAPEUTICS INC · $69.65M
  • IRON DISC MEDICINE INC · $20.60M
  • DNTH DIANTHUS THERAPEUTICS INC · $20.13M
  • MLTX MOONLAKE IMMUNOTHERAPEUTICS · $17.85M
  • CRNX CRINETICS PHARMACEUTICALS IN · $13.75M
  • VOR VOR BIOPHARMA INC · $13.49M
  • PHVS PHARVARIS N V · $12.26M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest 5AM Venture Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

5AM Venture Management, LLC is an SEC-registered 13F filer based in San Francisco, CA, United States. As of Q3 2026 it reported 15 US equity positions with a combined value of $297.01M. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: SAN FRANCISCO, CA, United States
  • SEC registration: 801-120173 (status: Approved), registered 2021-01-19
  • Regulatory AUM (Form ADV): $1.08B as of 2026-03-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 12 private funds, of which 1 hedge funds
  • Website: 5amventures.com

Portfolio Structure

  • 15 positions · $297.01M reported value (Q3 2026)
  • Top 10 holdings = 93.7% of reported value
  • Largest position: ARTV (ARTIVA BIOTHERAPEUTICS INC) at 46.8%
  • Average position size: $19.80M

Sector Tilt

  • Health Care 98.8%
  • Industrials 1.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 1 added, 6 reduced, 1 exited
  • 8 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 87.3%
Other 12.7%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 5.16M $70.50M 20.29%
20.29%
New
2 4.41M $69.65M 20.04%
20.04%
New
3 438.44K $20.60M 5.93%
5.93%
New
4 1.47M $20.13M 5.79%
5.79%
New
5 313.21K $17.85M 5.14%
5.14%
New
6 462.29K $13.75M 3.96%
3.96%
New
7 6.36M $13.49M 3.88%
3.88%
New
8 587.60K $12.26M 3.53%
3.53%
New
9 3.63M $12.24M 3.52%
3.52%
New
10 490.00K $9.83M 2.83%
2.83%
New
11 1.20M $8.55M 2.46%
2.46%
New
12 310.27K $8.54M 2.46%
2.46%
New
13 192.50K $8.39M 2.41%
2.41%
New
14 790.44K $7.71M 2.22%
2.22%
New
15 585.00K $6.48M 1.86%
1.86%
New
16 357.73K $6.42M 1.85%
1.85%
New
17 410.00K $6.29M 1.81%
1.81%
New
18 320.00K $6.28M 1.81%
1.81%
New
19 411.45K $5.67M 1.63%
1.63%
New
20 2.36M $5.34M 1.54%
1.54%
New
21 4.54M $5.31M 1.53%
1.53%
New
22 665.55K $4.25M 1.22%
1.22%
New
23 404.40K $4.06M 1.17%
1.17%
New
24 1.30M $1.66M 0.48%
0.48%
New
25 2.88M $1.24M 0.36%
0.36%
New
26 1.13M $1.07M 0.31%
0.31%
New

FAQ

What did 5AM Venture Management, LLC buy in 2023-Q3?

In its 2023-Q3 13F filing, 5AM Venture Management, LLC reported 26 equity positions worth $347.54M in aggregate; its largest disclosed positions were ELVN ($70.50M), TRDA ($69.65M), IRON ($20.60M).

How large is 5AM Venture Management, LLC's portfolio?

5AM Venture Management, LLC reported $347.54M of long equity holdings across 26 positions as of 2023-Q3. Top-10 holdings account for 74.9% of reported value.

What is 5AM Venture Management, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/5am-venture-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →